1,25(OH)2D3 induces 25(OH)D3-24-hydroxylase (24-OHase) in cultured skin fibroblasts from normal subjects. We evaluated 24-OHase induction by 1,25(OH)2D3 in skin fibroblasts from 10 normal subjects and from four unrelated patients with hereditary resistance to 1,25(OH)2D or vitamin D-dependent rickets type II (DD II). Fibroblasts were preincubated with varying concentrations of 1,25(OH)2D3 for 15 h and were then incubated with 0.5 microM [3H]25(OH)D3 at 37 degrees C for 30 min; lipid extracts of the cells were analyzed for [3H]24,25(OH)2D3 by high performance liquid chromatography and periodate oxidation. Apparent maximal [3H]24,25(OH)2D3 production in normal cell lines was 9 pmol/10(6) cells per 30 min and occurred after induction with 10(-8) M 1,25(OH)2D3. 24-OHase induction was detectable in normal fibroblasts at approximately 3 X 10(-10) M 1,25(OH)2D3. [3H]24,25(OH)2D3 formation after exposure to 1,25(OH)2D3 was abnormal in fibroblasts from all four patients with DD II. In fibroblasts from two patients with DD II, [3H]24,25(OH)2D3 formation was unmeasurable (below 0.2 pmol/10(6) cells per 30 min) at 1,25(OH)2D3 concentrations up to 10(-6) M. Fibroblasts from the other two patients with DD II required far higher than normal concentrations of 1,25(OH)2D3 for detectable [3H]24,25(OH)2D3 induction. In one, [3H]24,25(OH)2D3 production reached 2.9 pmol/10(6) cells per 30 min at 10(-6) M 1,25(OH)2D3 (30% normal maximum at 10(-6) M 1,25(OH)2D3). In the other, [3H]24,25(OH)2D3 production achieved normal levels, 7.3 pmol/10(6) cells per 30 min after 10(-6) M 1,25(OH)2D3. The two patients whose cells had a detectable 24-OHase induction by 1,25(OH)2D3 showed a calcemic response to high doses of calciferols in vivo. Our current observations correlate with these two patients' responsiveness to calciferols in vivo and suggest that their target organ defects can be partially or completely overcome with extremely high concentrations of 1,25(OH)2D3. The two patients whose cells showed no detectable 24-OHase induction in vitro failed to show a calcemic response to high doses of calciferols in vivo. In conclusion: (a) the measurement of 24-OHase induction by 1,25(OH)2D3 in cultured skin fibroblasts is a sensitive in vitro test for defective genes in the 1,25(OH)2D effector pathway. (b) This assay provides a useful tool for characterizing the target tissue defects in DD II and predicting response to calciferol therapy.
G T Gamblin, U A Liberman, C Eil, R W Downs Jr, D A DeGrange, S J Marx
Title and authors | Publication | Year |
---|---|---|
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio |
Emery and Rimoin's Principles and Practice of Medical Genetics | 2013 |
Rickets Due to Hereditary Abnormalities of Vitamin D Synthesis or Action
AA Portale, F Perwad, WL Miller |
Pediatric Bone | 2012 |
Pediatric Bone
M Bastepe, H Jüppner, RV Thakker |
Pediatric Bone | 2012 |
Hereditary 1,25-Dihydroxyvitamin-D-Resistant Rickets
PJ Malloy, D Tiosano, D Feldman |
Vitamin D | 2011 |
Principles of Bone Biology
CJ Rosen, T Niu |
Principles of Bone Biology | 2008 |
Vitamin D resistance
R Bouillon, A Verstuyf, C Mathieu, SV Cromphaut, R Masuyama, P Dehaes, G Carmeliet |
Best Practice & Research Clinical Endocrinology & Metabolism | 2006 |
Vitamin D-dependent rickets Type II with alopecia: two case reports and review of the literature
S Al-Khenaizan, P Vitale |
International Journal of Dermatology | 2003 |
The Genetics of Osteoporosis and Metabolic Bone Disease
MJ Econs |
2000 | |
Hormone Resistance Syndromes
JL Jameson |
1999 | |
The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets*
PJ Malloy, JW Pike, D Feldman |
Endocrine reviews | 1999 |
Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness
PJ Malloy, TR Eccleshall, C Gross, LV Maldergem, R Bouillon, D Feldman |
Journal of Clinical Investigation | 1997 |
Vitamin D-dependent rickets type I and type II
E Takeda, H Yamamoto, Y Taketani, KI Miyamoto |
Pediatrics International | 1997 |
Advances in Molecular and Cell Biology
KJ Clemetson |
Advances in Molecular and Cell Biology | 1997 |
Vitamin D receptor expression is required for growth modulation by 1α,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31
TE Hedlund, KA Moffatt, GJ Miller |
The Journal of Steroid Biochemistry and Molecular Biology | 1996 |
Vitamin D dependent rickets type II and normal vitamin D receptor cDNA sequence. A cluster in a rural area of Cauca, Colombia, with more than 200 affected children
A Giraldo, W Pino, LF García-Ramírez, M Pineda, A Iglesias |
Clinical Genetics | 1995 |
Calcitriol-resistant rickets due to vitamin D receptor defects
Z Hochberg, Y Weisman |
Trends in Endocrinology & Metabolism | 1995 |
Calcium transport in epithelial cells of the intestine and kidney
R Kumar |
Journal of Cellular Biochemistry | 1995 |
Vitamin D deficiency in veterans with chronic spinal cord injury
WA Bauman, YG Zhong, E Schwartz |
Metabolism | 1995 |
Advances in Drug Research
CL Crespi |
Advances in Drug Research | 1995 |
Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures
AR Rut, Y Hewlson, K Kristjansson, B Luisl, MR Hughes, JL O'Riordan |
Clinical Endocrinology | 1994 |
4 Vitamin D resistance
M Hewison, JL O'Riordan |
Baillière's Clinical Endocrinology and Metabolism | 1994 |
Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3
M Inaba, S Okuno, Y Nishizawa, Y Imanishi, T Katsumata, I Sugata, H Morii |
Biochemical Pharmacology | 1993 |
Biochemistry of Zinc
AS Prasad |
1993 | |
The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. Stimulation of Gs and inhibition of G(o)
MJ McPhaul, JP Deslypere, DR Allman, RD Gerard |
The Journal of biological chemistry | 1993 |
Characterization and regulation of the vitamin D hydroxylases
HJ Armbrecht, K Okuda, N Wongsurawat, RK Nemani, ML Chen, MA Boltz |
The Journal of Steroid Biochemistry and Molecular Biology | 1992 |
Calcium therapy for calcitriol-resistant rickets
Z Hochberg, D Tiosano, L Even |
The Journal of Pediatrics | 1992 |
Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis
ME Hayes, D Bayley, P Still, J Palit, J Denton, AJ Freemont, RG Cooper, EB Mawer |
Annals of the rheumatic diseases | 1992 |
Clinical and biochemical findings in parents of children with vitamin D-dependent rickets type II
I Yokota, E Takeda, M Ito, H Kobashi, T Saijo, Y Kuroda |
Journal of Inherited Metabolic Disease | 1991 |
Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction
MM Walka, S Däumling, HB Hadorn, K Kruse, BH Belohradsky |
European Journal of Pediatrics | 1991 |
Genetic Defects of the 1,25-Dihydroxyvitamin D3Receptor
MR Hughes, PJ Malloy, BW O'malley, JW Pike, D Feldman |
Journal of Receptors and Signal Transduction | 1991 |
(21) Type 2 vitamin D-dependent rickets with alopecia
M Sheehan, M Dillon, D Atherton |
British Journal of Dermatology | 1991 |
Characteristics of the 25-hydroxyvitamin D3- and 1,25-dihydroxyvitamin D3-24-hydroxylase(s) from HL-60 cells
M Inaba, M Burgos-Trinidad, HF DeLuca |
Archives of Biochemistry and Biophysics | 1991 |
Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction
MM Walka, S Däumling, , K Kruse, BH Belohradsky |
European Journal of Pediatrics | 1991 |
The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families
PJ Malloy, Z Hochberg, D Tiosano, JW Pike, MR Hughes, D Feldman |
Journal of Clinical Investigation | 1990 |
Hereditary 1,25-dihydroxyvitamin D resistant rickets: Molecular basis and implications for the role of 1,25(OH)2D3 in normal physiology
D Feldman, PJ Malloy |
Molecular and Cellular Endocrinology | 1990 |
Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor
D D'Ambrosio, M Cippitelli, MG Cocciolo, D Mazzeo, PD Lucia, R Lang, F Sinigaglia, P Panina-Bordignon |
Molecular and Cellular Endocrinology | 1990 |
Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1α,25-dihydroxyvitamin D3 receptor
HP Koeffler, JE Bishop, H Reichel, F Singer, A Nagler, A Tobler, M Walka, AW Norman |
Molecular and Cellular Endocrinology | 1990 |
Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor
J Barsony, W McKoy, DA DeGrange, UA Liberman, SJ Marx |
Journal of Clinical Investigation | 1989 |
Two siblings with vitamin-D-dependent rickets type II: No recurrence of rickets for 14 years after cessation of therapy
E Takeda, I Yokota, I Kawakami, T Hashimoto, Y Kuroda, S Arase |
European Journal of Pediatrics | 1989 |
An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families
HH Ritchie, MR Hughes, ET Thompson, PJ Malloy, Z Hochberg, D Feldman, JW Pike, BW O'Malley |
Proceedings of the National Academy of Sciences | 1989 |
Southwestern Internal Medicine Conference: Clinical Disorders of Renal Tubular Phosphate Transport
M Levi |
The American Journal of the Medical Sciences | 1989 |
Mutant vitamin D receptors which confer hereditary resistance to 1,25-dihydroxyvitamin D3 in humans are transcriptionally inactive in vitro
T Sone, RA Scott, MR Hughes, PJ Malloy, D Feldman, BW O'Malley, JW Pike |
The Journal of biological chemistry | 1989 |
Vitamin D
A Portale, Β Halloran, E Lonergan, R Morris |
Vitamin D | 1988 |
Tissue-selective 1,25-dihydroxyvitamin D3 resistance: Novel applications of calciferols
SJ Marx, J Barsony |
Journal of Bone and Mineral Research | 1988 |
Human Melanoma Cells: Functional Modulation by Calciotropic Hormones
RS Mason, AM Pryke, M Ranson, HE Thomas, S Posen |
Journal of Investigative Dermatology | 1988 |
Vitamin D and parotid gland function in the rat
C Peterfy, A Tenenhouse, E Yu |
The Journal of Physiology | 1988 |
Receptor-mediated rapid action of 1 alpha,25-dihydroxycholecalciferol: increase of intracellular cGMP in human skin fibroblasts
J Barsony, SJ Marx |
Proceedings of the National Academy of Sciences | 1988 |
6 Osteomalacia
JA Eisman |
Baillière's Clinical Endocrinology and Metabolism | 1988 |
Point mutations in the Human Vitamin D Receptor Gene Associated with Hypocalcemic Rickets
MR Hughes, PJ Malloy, DG Kieback, RA Kesterson, JW Pike, D Feldman, BW O'Malley |
Science | 1988 |
Endocrine control and disturbances of calcium and phosphate metabolism in children
K Kruse |
European Journal of Pediatrics | 1987 |
Regulation of 24-hydroxylase activity in mouse skin fibroblasts by cholecalciferol derivatives, triamcinolone acetonide and a calcium modulating agent, nicardipine
L Cancela, C Rebut-Bonneton |
Journal of Steroid Biochemistry | 1987 |
Hormone Resistance and Other Endocrine Paradoxes
MP Cohen, PP Foà |
1987 | |
ANALYSIS OF THE RELATION BETWEEN ALOPECIA AND RESISTANCE TO 1,25-DIHYDROXYVITAMIN D
SJ Marx, MM Bliziotes, M Nanes |
Clinical Endocrinology | 1986 |
Steroid Hormone Resistance
GP Chrousos, DL Loriaux, MB Lipsett |
1986 | |
Contemporary Nephrology
S Klahr, SG Massry |
1981 |